nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP1A2—chronic obstructive pulmonary disease	0.337	1	CbGaD
Tranylcypromine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0665	0.127	CbGbCtD
Tranylcypromine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0665	0.127	CbGbCtD
Tranylcypromine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0504	0.0962	CbGbCtD
Tranylcypromine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0373	0.0712	CbGbCtD
Tranylcypromine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0296	0.0564	CbGbCtD
Tranylcypromine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0275	0.0525	CbGbCtD
Tranylcypromine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0275	0.0525	CbGbCtD
Tranylcypromine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0229	0.0436	CbGbCtD
Tranylcypromine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0229	0.0436	CbGbCtD
Tranylcypromine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0216	0.0412	CbGbCtD
Tranylcypromine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0209	0.0399	CbGbCtD
Tranylcypromine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0209	0.0399	CbGbCtD
Tranylcypromine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0186	0.0356	CbGbCtD
Tranylcypromine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0176	0.0335	CbGbCtD
Tranylcypromine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0173	0.0331	CbGbCtD
Tranylcypromine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0119	0.0226	CbGbCtD
Tranylcypromine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0116	0.022	CbGbCtD
Tranylcypromine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0113	0.0216	CbGbCtD
Tranylcypromine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0101	0.0192	CbGbCtD
Tranylcypromine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00592	0.0113	CbGbCtD
Tranylcypromine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00559	0.0107	CbGbCtD
Tranylcypromine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000853	0.00997	CcSEcCtD
Tranylcypromine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000853	0.00997	CcSEcCtD
Tranylcypromine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.000806	0.00942	CcSEcCtD
Tranylcypromine—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.000774	0.00905	CcSEcCtD
Tranylcypromine—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00073	0.00853	CcSEcCtD
Tranylcypromine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000707	0.00826	CcSEcCtD
Tranylcypromine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.00805	CcSEcCtD
Tranylcypromine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.000678	0.00793	CcSEcCtD
Tranylcypromine—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.000649	0.00759	CcSEcCtD
Tranylcypromine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000623	0.00729	CcSEcCtD
Tranylcypromine—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.00677	CcSEcCtD
Tranylcypromine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00643	CcSEcCtD
Tranylcypromine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000542	0.00634	CcSEcCtD
Tranylcypromine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000522	0.00611	CcSEcCtD
Tranylcypromine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000521	0.0061	CcSEcCtD
Tranylcypromine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000513	0.006	CcSEcCtD
Tranylcypromine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000497	0.00582	CcSEcCtD
Tranylcypromine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000494	0.00578	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00049	0.00573	CcSEcCtD
Tranylcypromine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000476	0.00557	CcSEcCtD
Tranylcypromine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000474	0.00554	CcSEcCtD
Tranylcypromine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00547	CcSEcCtD
Tranylcypromine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00537	CcSEcCtD
Tranylcypromine—Phenylpropanolamine—ADRB2—chronic obstructive pulmonary disease	0.000457	0.184	CrCbGaD
Tranylcypromine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00527	CcSEcCtD
Tranylcypromine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.00526	CcSEcCtD
Tranylcypromine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00509	CcSEcCtD
Tranylcypromine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00506	CcSEcCtD
Tranylcypromine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00505	CcSEcCtD
Tranylcypromine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00043	0.00503	CcSEcCtD
Tranylcypromine—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00042	0.00491	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00488	CcSEcCtD
Tranylcypromine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.00486	CcSEcCtD
Tranylcypromine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00485	CcSEcCtD
Tranylcypromine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00041	0.0048	CcSEcCtD
Tranylcypromine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000408	0.00477	CcSEcCtD
Tranylcypromine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00475	CcSEcCtD
Tranylcypromine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.00475	CcSEcCtD
Tranylcypromine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.00473	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00471	CcSEcCtD
Tranylcypromine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00466	CcSEcCtD
Tranylcypromine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000397	0.00464	CcSEcCtD
Tranylcypromine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.0046	CcSEcCtD
Tranylcypromine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00456	CcSEcCtD
Tranylcypromine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.0045	CcSEcCtD
Tranylcypromine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000381	0.00446	CcSEcCtD
Tranylcypromine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000381	0.00446	CcSEcCtD
Tranylcypromine—Phenylpropanolamine—CYP1A2—chronic obstructive pulmonary disease	0.000378	0.152	CrCbGaD
Tranylcypromine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000378	0.00442	CcSEcCtD
Tranylcypromine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000378	0.00442	CcSEcCtD
Tranylcypromine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00441	CcSEcCtD
Tranylcypromine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.00441	CcSEcCtD
Tranylcypromine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000376	0.00439	CcSEcCtD
Tranylcypromine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00439	CcSEcCtD
Tranylcypromine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00437	CcSEcCtD
Tranylcypromine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000371	0.00434	CcSEcCtD
Tranylcypromine—Phentermine—SLC6A4—chronic obstructive pulmonary disease	0.00037	0.149	CrCbGaD
Tranylcypromine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.0043	CcSEcCtD
Tranylcypromine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00424	CcSEcCtD
Tranylcypromine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00423	CcSEcCtD
Tranylcypromine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00419	CcSEcCtD
Tranylcypromine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00419	CcSEcCtD
Tranylcypromine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000356	0.00416	CcSEcCtD
Tranylcypromine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00411	CcSEcCtD
Tranylcypromine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00409	CcSEcCtD
Tranylcypromine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00409	CcSEcCtD
Tranylcypromine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00406	CcSEcCtD
Tranylcypromine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00401	CcSEcCtD
Tranylcypromine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00401	CcSEcCtD
Tranylcypromine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000342	0.004	CcSEcCtD
Tranylcypromine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.00399	CcSEcCtD
Tranylcypromine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00396	CcSEcCtD
Tranylcypromine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00396	CcSEcCtD
Tranylcypromine—Phentermine—CYP1A2—chronic obstructive pulmonary disease	0.000337	0.135	CrCbGaD
Tranylcypromine—Benzyl alcohol—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.135	CrCbGaD
Tranylcypromine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00392	CcSEcCtD
Tranylcypromine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00386	CcSEcCtD
Tranylcypromine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00385	CcSEcCtD
Tranylcypromine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00385	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000327	0.00382	CcSEcCtD
Tranylcypromine—Benzyl alcohol—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.131	CrCbGaD
Tranylcypromine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00378	CcSEcCtD
Tranylcypromine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00377	CcSEcCtD
Tranylcypromine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000323	0.00377	CcSEcCtD
Tranylcypromine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00376	CcSEcCtD
Tranylcypromine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00376	CcSEcCtD
Tranylcypromine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000318	0.00371	CcSEcCtD
Tranylcypromine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.0037	CcSEcCtD
Tranylcypromine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000316	0.0037	CcSEcCtD
Tranylcypromine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.0037	CcSEcCtD
Tranylcypromine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.0037	CcSEcCtD
Tranylcypromine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00369	CcSEcCtD
Tranylcypromine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00364	CcSEcCtD
Tranylcypromine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00363	CcSEcCtD
Tranylcypromine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00363	CcSEcCtD
Tranylcypromine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00031	0.00362	CcSEcCtD
Tranylcypromine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00362	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000308	0.00361	CcSEcCtD
Tranylcypromine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00356	CcSEcCtD
Tranylcypromine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00356	CcSEcCtD
Tranylcypromine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00355	CcSEcCtD
Tranylcypromine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0003	0.0035	CcSEcCtD
Tranylcypromine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00349	CcSEcCtD
Tranylcypromine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00349	CcSEcCtD
Tranylcypromine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00349	CcSEcCtD
Tranylcypromine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00347	CcSEcCtD
Tranylcypromine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00347	CcSEcCtD
Tranylcypromine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00343	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00341	CcSEcCtD
Tranylcypromine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00336	CcSEcCtD
Tranylcypromine—Amphetamine—SLC6A4—chronic obstructive pulmonary disease	0.000285	0.114	CrCbGaD
Tranylcypromine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00333	CcSEcCtD
Tranylcypromine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00333	CcSEcCtD
Tranylcypromine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00331	CcSEcCtD
Tranylcypromine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00328	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00325	CcSEcCtD
Tranylcypromine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00322	CcSEcCtD
Tranylcypromine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00322	CcSEcCtD
Tranylcypromine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.0032	CcSEcCtD
Tranylcypromine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000274	0.0032	CcSEcCtD
Tranylcypromine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00316	CcSEcCtD
Tranylcypromine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00316	CcSEcCtD
Tranylcypromine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00315	CcSEcCtD
Tranylcypromine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00314	CcSEcCtD
Tranylcypromine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00313	CcSEcCtD
Tranylcypromine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000265	0.0031	CcSEcCtD
Tranylcypromine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00309	CcSEcCtD
Tranylcypromine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00304	CcSEcCtD
Tranylcypromine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00304	CcSEcCtD
Tranylcypromine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00304	CcSEcCtD
Tranylcypromine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00304	CcSEcCtD
Tranylcypromine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00304	CcSEcCtD
Tranylcypromine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00303	CcSEcCtD
Tranylcypromine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00302	CcSEcCtD
Tranylcypromine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00299	CcSEcCtD
Tranylcypromine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00298	CcSEcCtD
Tranylcypromine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.00297	CcSEcCtD
Tranylcypromine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00295	CcSEcCtD
Tranylcypromine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00295	CcSEcCtD
Tranylcypromine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00293	CcSEcCtD
Tranylcypromine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00293	CcSEcCtD
Tranylcypromine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000251	0.00293	CcSEcCtD
Tranylcypromine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00292	CcSEcCtD
Tranylcypromine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00292	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00291	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00291	CcSEcCtD
Tranylcypromine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00287	CcSEcCtD
Tranylcypromine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00287	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00285	CcSEcCtD
Tranylcypromine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00283	CcSEcCtD
Tranylcypromine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00283	CcSEcCtD
Tranylcypromine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00281	CcSEcCtD
Tranylcypromine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000241	0.00281	CcSEcCtD
Tranylcypromine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00281	CcSEcCtD
Tranylcypromine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.00281	CcSEcCtD
Tranylcypromine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.0028	CcSEcCtD
Tranylcypromine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00278	CcSEcCtD
Tranylcypromine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00278	CcSEcCtD
Tranylcypromine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000238	0.00278	CcSEcCtD
Tranylcypromine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00277	CcSEcCtD
Tranylcypromine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00277	CcSEcCtD
Tranylcypromine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00276	CcSEcCtD
Tranylcypromine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00276	CcSEcCtD
Tranylcypromine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00276	CcSEcCtD
Tranylcypromine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000236	0.00276	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00275	CcSEcCtD
Tranylcypromine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.00273	CcSEcCtD
Tranylcypromine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00271	CcSEcCtD
Tranylcypromine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00267	CcSEcCtD
Tranylcypromine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00266	CcSEcCtD
Tranylcypromine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00266	CcSEcCtD
Tranylcypromine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00262	CcSEcCtD
Tranylcypromine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00255	CcSEcCtD
Tranylcypromine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00255	CcSEcCtD
Tranylcypromine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000214	0.0025	CcSEcCtD
Tranylcypromine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00243	CcSEcCtD
Tranylcypromine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00243	CcSEcCtD
Tranylcypromine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00241	CcSEcCtD
Tranylcypromine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00238	CcSEcCtD
Tranylcypromine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00235	CcSEcCtD
Tranylcypromine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00235	CcSEcCtD
Tranylcypromine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000197	0.0023	CcSEcCtD
Tranylcypromine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.0023	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00227	CcSEcCtD
Tranylcypromine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00226	CcSEcCtD
Tranylcypromine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00226	CcSEcCtD
Tranylcypromine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00224	CcSEcCtD
Tranylcypromine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00224	CcSEcCtD
Tranylcypromine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00224	CcSEcCtD
Tranylcypromine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00224	CcSEcCtD
Tranylcypromine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00223	CcSEcCtD
Tranylcypromine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00223	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00223	CcSEcCtD
Tranylcypromine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00222	CcSEcCtD
Tranylcypromine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00222	CcSEcCtD
Tranylcypromine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000188	0.0022	CcSEcCtD
Tranylcypromine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000188	0.0022	CcSEcCtD
Tranylcypromine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00218	CcSEcCtD
Tranylcypromine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00214	CcSEcCtD
Tranylcypromine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00212	CcSEcCtD
Tranylcypromine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.00212	CcSEcCtD
Tranylcypromine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00212	CcSEcCtD
Tranylcypromine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00211	CcSEcCtD
Tranylcypromine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00211	CcSEcCtD
Tranylcypromine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.0021	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.00208	CcSEcCtD
Tranylcypromine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00207	CcSEcCtD
Tranylcypromine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.00204	CcSEcCtD
Tranylcypromine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00201	CcSEcCtD
Tranylcypromine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.002	CcSEcCtD
Tranylcypromine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00198	CcSEcCtD
Tranylcypromine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00197	CcSEcCtD
Tranylcypromine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00193	CcSEcCtD
Tranylcypromine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.0019	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00188	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00186	CcSEcCtD
Tranylcypromine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00183	CcSEcCtD
Tranylcypromine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00174	CcSEcCtD
Tranylcypromine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00174	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00173	CcSEcCtD
Tranylcypromine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00165	CcSEcCtD
Tranylcypromine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00162	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00159	CcSEcCtD
Tranylcypromine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00159	CcSEcCtD
Tranylcypromine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00158	CcSEcCtD
Tranylcypromine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00154	CcSEcCtD
Tranylcypromine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00153	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00151	CcSEcCtD
Tranylcypromine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00148	CcSEcCtD
Tranylcypromine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00146	CcSEcCtD
Tranylcypromine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00012	0.0014	CcSEcCtD
Tranylcypromine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00138	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00137	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00135	CcSEcCtD
Tranylcypromine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00133	CcSEcCtD
Tranylcypromine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00127	CcSEcCtD
Tranylcypromine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00127	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00126	CcSEcCtD
Tranylcypromine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00122	CcSEcCtD
Tranylcypromine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00122	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00121	CcSEcCtD
Tranylcypromine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00121	CcSEcCtD
Tranylcypromine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000102	0.0012	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.87e-05	0.00115	CcSEcCtD
Tranylcypromine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.86e-05	0.00196	CbGpPWpGaD
Tranylcypromine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.8e-05	0.00195	CbGpPWpGaD
Tranylcypromine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.00115	CcSEcCtD
Tranylcypromine—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.79e-05	0.00114	CcSEcCtD
Tranylcypromine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.64e-05	0.00192	CbGpPWpGaD
Tranylcypromine—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.00111	CcSEcCtD
Tranylcypromine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.51e-05	0.00189	CbGpPWpGaD
Tranylcypromine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.00111	CcSEcCtD
Tranylcypromine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.00111	CcSEcCtD
Tranylcypromine—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.37e-05	0.00186	CbGpPWpGaD
Tranylcypromine—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.29e-05	0.00185	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	9.29e-05	0.00185	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	9.29e-05	0.00185	CbGpPWpGaD
Tranylcypromine—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.25e-05	0.00184	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.15e-05	0.00182	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.05e-05	0.0018	CbGpPWpGaD
Tranylcypromine—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	9.02e-05	0.0018	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.91e-05	0.00177	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	8.91e-05	0.00177	CbGpPWpGaD
Tranylcypromine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.86e-05	0.00176	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	8.85e-05	0.00176	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.8e-05	0.00175	CbGpPWpGaD
Tranylcypromine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.79e-05	0.00175	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	8.78e-05	0.00175	CbGpPWpGaD
Tranylcypromine—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.77e-05	0.00174	CbGpPWpGaD
Tranylcypromine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.75e-05	0.00174	CbGpPWpGaD
Tranylcypromine—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.69e-05	0.00173	CbGpPWpGaD
Tranylcypromine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.67e-05	0.00172	CbGpPWpGaD
Tranylcypromine—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.001	CcSEcCtD
Tranylcypromine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000958	CcSEcCtD
Tranylcypromine—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	8.18e-05	0.00163	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.16e-05	0.00162	CbGpPWpGaD
Tranylcypromine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.97e-05	0.00159	CbGpPWpGaD
Tranylcypromine—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000926	CcSEcCtD
Tranylcypromine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.87e-05	0.00157	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.81e-05	0.00155	CbGpPWpGaD
Tranylcypromine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.81e-05	0.00155	CbGpPWpGaD
Tranylcypromine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.00089	CcSEcCtD
Tranylcypromine—Rash—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000883	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.55e-05	0.000882	CcSEcCtD
Tranylcypromine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.51e-05	0.00149	CbGpPWpGaD
Tranylcypromine—Headache—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000877	CcSEcCtD
Tranylcypromine—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.45e-05	0.00148	CbGpPWpGaD
Tranylcypromine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.41e-05	0.00147	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.4e-05	0.00147	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.3e-05	0.00145	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	7.24e-05	0.00144	CbGpPWpGaD
Tranylcypromine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.18e-05	0.00143	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.18e-05	0.00143	CbGpPWpGaD
Tranylcypromine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.17e-05	0.00143	CbGpPWpGaD
Tranylcypromine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.12e-05	0.00142	CbGpPWpGaD
Tranylcypromine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000832	CcSEcCtD
Tranylcypromine—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	7.05e-05	0.0014	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.87e-05	0.00137	CbGpPWpGaD
Tranylcypromine—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.81e-05	0.00135	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.79e-05	0.00135	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.73e-05	0.00134	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.46e-05	0.00129	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.34e-05	0.00126	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.32e-05	0.00126	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.27e-05	0.00125	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.25e-05	0.00124	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.19e-05	0.00123	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.17e-05	0.00123	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.09e-05	0.00121	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.09e-05	0.00121	CbGpPWpGaD
Tranylcypromine—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.83e-05	0.00116	CbGpPWpGaD
Tranylcypromine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.79e-05	0.00115	CbGpPWpGaD
Tranylcypromine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.00114	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.71e-05	0.00114	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.67e-05	0.00113	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.63e-05	0.00112	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.6e-05	0.00111	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.48e-05	0.00109	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.47e-05	0.00109	CbGpPWpGaD
Tranylcypromine—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.38e-05	0.00107	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.35e-05	0.00107	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.00106	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.29e-05	0.00105	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00104	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.24e-05	0.00104	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.21e-05	0.00104	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.18e-05	0.00103	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.14e-05	0.00102	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.14e-05	0.00102	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.83e-05	0.000961	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.76e-05	0.000947	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.7e-05	0.000934	CbGpPWpGaD
Tranylcypromine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.7e-05	0.000934	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.67e-05	0.000929	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	4.54e-05	0.000904	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.44e-05	0.000883	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.4e-05	0.000876	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.000871	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.38e-05	0.000871	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.35e-05	0.000865	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.34e-05	0.000864	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.33e-05	0.000861	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.32e-05	0.000859	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.32e-05	0.000859	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.28e-05	0.000852	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.22e-05	0.00084	CbGpPWpGaD
Tranylcypromine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.15e-05	0.000825	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.13e-05	0.000822	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.09e-05	0.000814	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.08e-05	0.000812	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.03e-05	0.000801	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.99e-05	0.000794	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.000794	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.97e-05	0.00079	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.96e-05	0.000787	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.94e-05	0.000783	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.000779	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.91e-05	0.000779	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	3.91e-05	0.000778	CbGpPWpGaD
Tranylcypromine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.000759	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.81e-05	0.000757	CbGpPWpGaD
Tranylcypromine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.000753	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.000749	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.76e-05	0.000749	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.73e-05	0.000742	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.73e-05	0.000742	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.73e-05	0.000742	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.71e-05	0.000738	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.66e-05	0.000728	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.63e-05	0.000721	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.57e-05	0.00071	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.53e-05	0.000702	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.43e-05	0.000683	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.41e-05	0.000678	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.000674	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.36e-05	0.000669	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.34e-05	0.000664	CbGpPWpGaD
Tranylcypromine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.34e-05	0.000664	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.29e-05	0.000654	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.28e-05	0.000652	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000643	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.19e-05	0.000634	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.07e-05	0.000611	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.07e-05	0.000611	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.04e-05	0.000605	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.87e-05	0.00057	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.86e-05	0.00057	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.82e-05	0.000562	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.79e-05	0.000555	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.74e-05	0.000546	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.7e-05	0.000538	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.63e-05	0.000524	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.6e-05	0.000517	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.6e-05	0.000516	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.59e-05	0.000516	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.52e-05	0.000501	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.5e-05	0.000496	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.48e-05	0.000494	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.00049	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	2.45e-05	0.000488	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.39e-05	0.000475	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000473	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	2.24e-05	0.000445	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.21e-05	0.00044	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000436	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.17e-05	0.000432	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.15e-05	0.000428	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.00041	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.03e-05	0.000405	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.02e-05	0.000401	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.01e-05	0.000399	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2e-05	0.000398	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2e-05	0.000398	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.98e-05	0.000394	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.96e-05	0.00039	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.93e-05	0.000383	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.91e-05	0.000379	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000369	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.84e-05	0.000366	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.82e-05	0.000363	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.74e-05	0.000346	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.72e-05	0.000343	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.72e-05	0.000342	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.7e-05	0.000338	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.68e-05	0.000333	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000323	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.6e-05	0.000319	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000317	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.000315	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.56e-05	0.00031	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.55e-05	0.000309	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.52e-05	0.000303	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.51e-05	0.000299	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000298	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.000289	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.37e-05	0.000273	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.34e-05	0.000266	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.33e-05	0.000265	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.32e-05	0.000262	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.29e-05	0.000257	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.27e-05	0.000252	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000247	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.23e-05	0.000244	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.2e-05	0.000239	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.18e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000232	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000215	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.000215	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.07e-05	0.000213	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.000213	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.06e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.00021	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.04e-05	0.000207	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000203	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.88e-06	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.77e-06	0.000194	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.75e-06	0.000194	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	9.75e-06	0.000194	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.7e-06	0.000193	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.67e-06	0.000192	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.2e-06	0.000183	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.16e-06	0.000182	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.05e-06	0.00018	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.98e-06	0.000179	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.9e-06	0.000177	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.44e-06	0.000168	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.26e-06	0.000164	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.15e-06	0.000162	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.03e-06	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	7.91e-06	0.000157	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.57e-06	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.49e-06	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.49e-06	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.43e-06	0.000148	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.39e-06	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.32e-06	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.1e-06	0.000141	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.07e-06	0.000141	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.99e-06	0.000139	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.88e-06	0.000137	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.83e-06	0.000136	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.53e-06	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.47e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.37e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.35e-06	0.000126	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.26e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.25e-06	0.000124	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.98e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.87e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.83e-06	0.000116	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.53e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.9e-06	9.74e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.83e-06	9.61e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.82e-06	9.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.61e-06	9.18e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.5e-06	8.95e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.44e-06	8.82e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.4e-06	8.75e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.27e-06	8.49e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.24e-06	8.44e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.21e-06	8.37e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-06	7.48e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-06	7.15e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.9e-06	5.77e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.77e-06	5.52e-05	CbGpPWpGaD
